DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Esposito S, Birlutiu V, Jarcuska P, Perino A, Man SC, Vladareanu R et al.
Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine administered
according to an alternative dosing schedule compared with the standard dosing schedule in healthy
women aged 15 to 25 years: results from a randomized study.
Ped Inf Dis J 2011;
30: e49-e55
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.